首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Ruthenium(III) Complexes of Heterocyclic Tridentate (ONN) Schiff Base: Synthesis Characterization and its Biological Properties as an Antiradical and Antiproliferative Agent
【2h】

Ruthenium(III) Complexes of Heterocyclic Tridentate (ONN) Schiff Base: Synthesis Characterization and its Biological Properties as an Antiradical and Antiproliferative Agent

机译:杂环三齿(ONN)Schiff碱钌(III)配合物:合成表征及其作为抗自由基和抗增殖剂的生物学性质

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The current work reports the synthesis, spectroscopic studies, antiradical and antiproliferative properties of four ruthenium(III) complexes of heterocyclic tridentate Schiff base bearing a simple 2′,4′-dihydroxyacetophenone functionality and ethylenediamine as the bridging ligand with RCHO moiety. The reaction of the tridentate ligands with RuCl3·3H2O lead to the formation of neutral complexes of the type [Ru(L)Cl2(H2O)] (where L = tridentate NNO ligands). The compounds were characterized by elemental analysis, UV-vis, conductivity measurements, FTIR spectroscopy and confirmed the proposed octahedral geometry around the Ru ion. The Ru(III) compounds showed antiradical potentials against 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) and 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radicals, with DPPH scavenging capability in the order: [(PAEBOD)RuCl2] > [(BZEBOD)RuCl2] > [(MOABOD)RuCl2] > [Vit. C] > [rutin] > [(METBOD)RuCl2], and ABTS radical in the order: [(PAEBOD)RuCl2] < [(MOABOD)RuCl2] < [(BZEBOD)RuCl2] < [(METBOD)RuCl2]. Furthermore, in vitro anti-proliferative activity was investigated against three human cancer cell lines: renal cancer cell (TK-10), melanoma cancer cell (UACC-62) and breast cancer cell (MCF-7) by SRB assay.
机译:当前的工作报道了杂环三齿席夫碱的四个钌(III)配合物的合成,光谱研究,抗自由基和抗增殖性能,这些席夫碱具有简单的2',4'-二羟基苯乙酮官能团和乙二胺作为具有RCHO部分的桥联配体。三齿配体与RuCl3·3H2O的反应导致形成[Ru(L)Cl2(H2O)]类型的中性络合物(其中L =三齿NNO配体)。通过元素分析,紫外可见,电导率测量,FTIR光谱对化合物进行表征,并证实了Ru离子周围拟议的八面体几何形状。 Ru(III)化合物显示出对2,2-二苯基-1-吡啶并肼基(DPPH)和2,2'-叠氮基双-(3-乙基苯并噻唑啉-6-磺酸)(ABTS)自由基的抗自由基能力,具有清除DPPH的能力。顺序:[(PAEBOD)RuCl2]> [(BZEBOD)RuCl2]> [(MOABOD)RuCl2]> [Vit。 C]> [芦丁]> [(METBOD)RuCl2]和ABTS自由基的顺序为:[(PAEBOD)RuCl2] <[(MOABOD)RuCl2] <[(BZEBOD)RuCl2] <[(METBOD)RuCl2]。此外,通过SRB分析研究了针对三种人类癌细胞系的体外抗增殖活性:肾癌细胞(TK-10),黑素瘤癌细胞(UACC-62)和乳腺癌细胞(MCF-7)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号